High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma
Authors:
- Paul LikhariPLPaul Likhari
- Donald ParkerDPDonald Parker
- Paul StatkevichPSPaul Statkevich
- Aliceann MarcoAMAliceann Marco
- Chin-Chung LinCLChin-Chung Lin
- Amin A. NomeirANAmin A. Nomeir
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 24 (3) , 461-468
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cellsBritish Journal of Cancer, 1993
- Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamideCancer Chemotherapy and Pharmacology, 1991
- A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladderEuropean Journal of Cancer and Clinical Oncology, 1989
- Phase II evaluation of mitozolomide in ovarian cancerBritish Journal of Cancer, 1988
- In vivo metabolism and reaction with dna of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC)Biochemical Pharmacology, 1986
- Antitumour imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agentJournal of Medicinal Chemistry, 1984
- Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-Dimethyl-1-triazeno)-imidazole 5(4)-carboxomideToxicology and Applied Pharmacology, 1971